Hcltech Malaysia Careers Digital Engineering Cloud Hcltech 5 reasons why hcl tech shares crashed 10%: targets as m cap slips below itc, 4 others hcl tech declined 9.7 per cent to hit a low of rs 1,301.60 on bse, taking its market capitalisation (m cap) to. Hcltech lost $4.5 billion in market capitalisation on wednesday after it projected fiscal 2027 revenue growth below estimates, with restrained client spending raising fresh doubts over a recovery.
Discover Hcltech Hcltech Revenue grew, deal wins were steady, and the company is actively building its ai business. but markets are rarely driven by surface level numbers. the fall was more about what the results are signalling about the future. At around 9:18 am, hcltech was the biggest hit among it stocks, plunging 9.1% to rs 1,310.05 after its earnings update. infosys fell 2.5% to rs 1,280.85, tata consultancy services slipped 1.7% to rs 2,565, while tech mahindra dropped 3.8% to rs 1,443.30. India business news: hcl share price today: shares of hcl technologies came under heavy selling pressure, plunging over 10% to rs 1,289 on the nse on wednesday. the sharp . Hcl tech, infosys to tcs: it stocks crash up to 10% today — what's behind the massive selloff? shares of leading it stocks witnessed a massive decline in the early morning trade on wednesday, 22.
Hcltech India business news: hcl share price today: shares of hcl technologies came under heavy selling pressure, plunging over 10% to rs 1,289 on the nse on wednesday. the sharp . Hcl tech, infosys to tcs: it stocks crash up to 10% today — what's behind the massive selloff? shares of leading it stocks witnessed a massive decline in the early morning trade on wednesday, 22. Hcltech q4 earnings soured investor sentiment in dalal street, with brokerages having already reined in on the it major, issuing significant target price cuts. Hcltech shares fall 11% to a 52 week low, marking their worst single day return in 11 years according to nuvama, hcltech's weak guidance for fy27 now converges its growth differential with tcs and infosys, which is likely to lead to convergence of their valuations. Hcltech shares plunged nearly 9% in early trade on wednesday after the company reported a softer than expected march quarter and issued cautious fy27 guidance, dragging the broader it pack lower. Hcltech helps fonterra in business processes transformation, resulting in a 30% boost in performance. we helped a leading pharmaceutical company achieve 95% customer satisfaction and rems compliance through patient monitoring services, enhancing operational efficiency and patient safety.
Start Your Tech Career With Hcltech New Zealand Hcltech Hcltech q4 earnings soured investor sentiment in dalal street, with brokerages having already reined in on the it major, issuing significant target price cuts. Hcltech shares fall 11% to a 52 week low, marking their worst single day return in 11 years according to nuvama, hcltech's weak guidance for fy27 now converges its growth differential with tcs and infosys, which is likely to lead to convergence of their valuations. Hcltech shares plunged nearly 9% in early trade on wednesday after the company reported a softer than expected march quarter and issued cautious fy27 guidance, dragging the broader it pack lower. Hcltech helps fonterra in business processes transformation, resulting in a 30% boost in performance. we helped a leading pharmaceutical company achieve 95% customer satisfaction and rems compliance through patient monitoring services, enhancing operational efficiency and patient safety.
Hcltech Transforming Brand Identity To Enhance Global Growth Brand Hcltech shares plunged nearly 9% in early trade on wednesday after the company reported a softer than expected march quarter and issued cautious fy27 guidance, dragging the broader it pack lower. Hcltech helps fonterra in business processes transformation, resulting in a 30% boost in performance. we helped a leading pharmaceutical company achieve 95% customer satisfaction and rems compliance through patient monitoring services, enhancing operational efficiency and patient safety.
Comments are closed.